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INRODUCTION 
The Molecular formula of Diclofenac sodium is 
C14H10O2CL2N.Na and chemical name, 2-[(2, 6-
dichlorophenyl)-amino] phenyl acetate. It is freely soluble 
in methanol, soluble in ethanol (95%), sparingly soluble in 
water and glacial acetic acid, practically insoluble in ether, 
chloroform and toluene. 
Diclofenac has analgesic, antipyretic and anti- 
inflammatory activities. It is a potent relatively non-
selective cyclooxygenase inhibitor and its potency is 
greater than that of indomethacin, naproxen, or several 
other agents. In addition, diclofenac appears to reduce 
intracellular concentration of free arachidonate in 
leucocytes, perhaps by altering the release or uptake of the 
fatty acid. Diclofenac is rapidly and completely absorbed 
after oral administration; peak Concentrations in plasma are 
reached within 2-3 hours. It is given in the dosage 75-
150mg daily in divided doses 1-5. 
Sustained release drug delivery system is designed to 
achieve a prolonged therapeutic effect by continuously 
releasing medication over an extended period of time after 
administration of a single dose. Multimedia dissolution is 
to mimic the in-vivo condition by doing in-vitro test and 
pH/buffer selection is based on the exposure of drug from 
stomach to intestine/colon and to ensure the impact of pH 
changes on dissolution and release of drug substance for 
absorption 7-9. 
 MATERIALS UNDER METHODS  
Diclofenac sodium sustained release tablets were purchased 
from the market. The drug content in each tablet was 
100mg. Calcium chloride, sodium hydroxide, potassium 
dihydrogen phosphate, oxalic acid,  
Sodium chloride and other reagents used were of analytical 
grade. Eqiupments used were UV/visible 
spectrophotometer - SHIMADZU-1700, Tablet dissolution 
test apparatus USP III paddle and Friability test apparatus 
(Rosche Friabilator). 
Physical Characterization: 
The tablets were subjected to their physical 
characterization, Hardness, friability and weight variation.  
 Assay:  The assay was performed by triturating the tablets 
to form a fine powder and transferred to a 100 ml 
volumetric flask and dissolved in phosphate buffer pH 7.2 
and made up to the volume to get stock solution. 1ml of 
this stock solution was taken in a 100ml volumetric flask 
and diluted with phosphate buffer pH 7.2 and made up to 
the volume. The absorbance of this solution was measured 
at 276nm using uv spectrophotometer. The drug content 
was estimated from the absorbance obtained. 
DISSOLUTION STUDIES  
In order to study the effect of the dissolution medium pH 
on the drug release pattern, drug release was studied in 
phosphate buffer of pH 2.4, 6.8 and 7.4. The dissolution 
mediums of different pH were prepared in following 
manner  
Simulated Gastric fluid – 2g of NaCl and 3.2 g of pepsin 
were dissolved in water. Then added 80 ml. of 1 M HCl 
and diluted to 1000 ml. with water. 
Phosphate buffer pH 6.8 –28.80 g of Na2HPO4 and 11.45 
g. of KH2PO4 were dissolved in sufficient water to produce 
1000 ml. 
Phosphate buffer ph 7.4 – Solution I – 119.31 g of 
Na2HPO4   was dissolved in  sufficient water to produce 
1000 ml. Solution II – 45.36 g of KH2PO4  was dissolved 
in  sufficient water to produce 1000 ml. Then 85 ml. of 
solution I and 15 ml. of solution II were mixed and adjusted 
the pH. 
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RESULTS AND DISCUSSION 
Physical properties of the tablets were found within the 
probable limits as shown in Table (1). The drug content 
was estimated from the absorbance obtained. Three tablets 
of were taken into three different pH of phosphate buffer 
(pH2.4, pH 6.8 and pH 7.4).The USP dissolution apparatus 
was set at rotation 50 rpm and temperature of the assembly 
was set at 370 C. The tablets were placed in above prepared 
three different media of different pH. Absorbance was 
determined at 276 nm by collecting sample at different time 
intervals up to 12hrs. The percentage drug release was 
calculated at different time intervals at different pH and 
shown in Table (2).  The graph was plotted between percent 
drug release and time for different dissolution media and 
shown in Fig (1). 
 
 
Figure 1: Percent drug release V/s Time 
Table 1: Physical characteristics of the tablets 
 Tablet Hardness (kg./cm.
2 
) Average % weight variation % Friability % Drug content                         
Marketed Sustained 
Release 
7 to 7.5 0.702 0.22 101.86 
 
Table 2: Result of dissolution studies with different pH 
Sr. No. Time hrs.  Absorbance (nm.) % Drug release 
pH 2.4 pH 6.8 pH 7.4 pH 2.4 pH 6.8 pH 7.4 
1. .5 0.069 0.074 0.228 8.896 9.66 29.39 
2. 1 0.100 0.123 0.259 12.89 15.85 33.38 
3. 1.5 0.113 0.131 0.324 14.56 16.88 41.83 
4. 3.00 0.130 0.246 0.505 16.75 31.71 65.08 
5. 5.5 0.172 0.346 0.608 22.16 44.60 78.38 
6. 6.00 0.181 0.380 0.619 23.33 48.96 79.80 
7. 8.5 0.270 0.452 0.650 31.31 58.35 83.80 
8. 10.5 0.345 0.619 0.733 44.54 79.80 94.48 
9. 12.00 0.449 0.658 0.756 57.96 84.90 97.55 
              
CONCLUSION 
The release profile of diclofenac sodium from the tablets 
increased continuously with time, and the amount of drug 
release increased as the media pH increased. The 
cumulative amount of drug release is higher at pH 7.4 than 
that of pH 6.8 by 15 %. This increase in drug release at 
higher pH can be attributed to pH dependent solubility of of 
diclofenac sodium.  As the pH increases, the solubility of 
diclofenac sodium increases which might increase drug 
release. 
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